subject area of
-
Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial
Academic Article -
Economic impact of delaying initiation with multiple-inhaler maintenance triple therapy in Spanish patients with chronic obstructive pulmonary disease
Academic Article -
Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature Review
Academic Article - A Critical Analysis of Studies of State Drug Reimbursement Policies: Research in Need of Discipline Academic Article
- A Model for Assessing the Cost-Effectiveness of Atorvastatin and Simvastatin in Achieving Canadian Low-Density Lipoprotein Cholesterol Targets Academic Article
- A Multinational Pharmacoeconomic Evaluation of Acute Major Depressive Disorder (MDD): a Comparison of Cost-Effectiveness Between Venlafaxine, SSRIs and TCAs Academic Article
- A Randomized Trial Comparing Omeprazole, Ranitidine, Cisapride, or Placebo in Helicobacter pylori Negative, Primary Care Patients with Dyspepsia: The CADET-HN Study Academic Article
- A SECOND LOOK AT PHARMACEUTICAL SPENDING AS DETERMINANTS OF HEALTH OUTCOMES IN CANADA Academic Article
- A Time‐Trend Economic Analysis of Cancer Drug Trials Academic Article
- A pharmacoeconomic evaluation of two new products for the treatment of overactive bladder. Academic Article
- A pilot study on cost-related medication nonadherence in Ontario. Academic Article
- A population-based analysis of incentive payments to primary care physicians for the care of patients with complex disease Academic Article
- A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma. Academic Article
- A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results Academic Article
- A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. Conference Paper
- A reappraisal of generic bisphosphonates in osteoporosis Academic Article
- A review and economic evaluation of bronchodilator delivery methods in hospitalized patients Academic Article
- An economic evaluation of combination treatment with budesonide and formoterol in patients with mild-to-moderate persistent asthma Academic Article
- Andexanet alfa for the treatment of hemorrhage Academic Article
- Antifibrinolytics may be cost saving among recent recipients of combined acetylsalicylic acid and clopidogrel who undergo coronary artery bypass graft surgery. Academic Article
- Antihypertensive treatment – navigating between cost, compliance and complications Academic Article
- At-risk registers integrated into primary care to stop asthma crises in the UK (ARRISA-UK): study protocol for a pragmatic, cluster randomised trial with nested health economic and process evaluations Academic Article
- Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Academic Article
- Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: A multicenter survey Academic Article
- Botulinum Toxin Type A and Acute Drug Costs in Migraine with Triptan Overuse Academic Article
- COST-effectiveness of salmeterol/fluticasone propionate combination (Advair®) in uncontrolled asthma in Canada Academic Article
- Calculating the Affordability of Antiretrovirals in St Lucia Academic Article
- Canadian Economic Evaluation of Budesonide-Formoterol as Maintenance and Reliever Treatment in Patients with Moderate to Severe Asthma Academic Article
- Canadian cost- utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura. Academic Article
- Cancer Care Ontario's New Drug Funding Program: controlled introduction of expensive anticancer drugs. Academic Article
- Chemotherapy waste reduction through shelf-life extension. Academic Article
- Combination Therapy to Prevent Cardiovascular Disease Academic Article
- Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges Academic Article
- Cost Implications of the Use of Ramipril in High-Risk Patients Based on the Heart Outcomes Prevention Evaluation (HOPE) Study Academic Article
- Cost effectiveness analysis of population-based serology screening and 13C-Urea breath test for Helicobacter pylori to prevent gastric cancer: A markov model Academic Article
- Cost implications of the use of basal insulin glargine in people with early dysglycemia: The ORIGIN trial Academic Article
- Cost prediction models for the comparison of two groups Academic Article
- Cost-Effectiveness Analysis of a Randomized Trial Comparing Care Models for Chronic Kidney Disease Academic Article
- Cost-Effectiveness of Dronedarone in Patients With Atrial Fibrillation in the ATHENA Trial Academic Article
- Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis Academic Article
- Cost-effectiveness analysis of secukinumab for the treatment of active psoriatic arthritis: a Canadian perspective Academic Article
- Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK Academic Article
- Cost-effectiveness of clopidogrel in acute coronary syndromes in Sweden: a long-term model based on the cure trial Academic Article
- Costs of Remission and Recovery Using Family Therapy for Adolescent Anorexia Nervosa: A Descriptive Report Academic Article
- Design of Effective Health Decision Support Systems: Towards Automating the Health Administrator's Decision Processes Academic Article
- Direct and indirect costs incurred by Australian living kidney donors Academic Article
- Direct and indirect costs of management of long-term warfarin therapy in Canada Academic Article
- Drug Reimbursement Policies in Canada—Need for Improved Access to Critical Therapies Academic Article
- Earlier Initialization of Highly Active Antiretroviral Therapy Is Associated With Long-Term Survival and Is Cost-Effective Academic Article
- Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme Academic Article
- Economic analysis of Neoral in de novo renal transplant patients in Canada. Academic Article
- Economic analysis of epoetin alfa in critically ill trauma patients Academic Article
- Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial Academic Article
- Economic issues in glycoprotein IIb/IIIa receptor therapy Academic Article
- Effect of a Proton Pump Inhibitor Deprescribing Guideline on Drug Usage and Costs in Long-Term Care Academic Article
- Efficacy and Cost of Low-Molecular-Weight Heparin Compared with Standard Heparin for the Prevention of Deep Vein Thrombosis after Total Hip Arthroplasty Academic Article
- Erectile dysfunction in spinal cord injury: a cost-utility analysis Academic Article
- Erythropoietin in the management of patients with nonhematologic cancer receiving chemotherapy. Systemic Treatment Program Committee. Academic Article
- Evaluating the impact of reference-based pricing. Academic Article
- Evaluation of Subcutaneous Rituximab Administration on Canadian Systemic Therapy Suites Academic Article
- Factor IX pharmacokinetics: differences between plasma-derived and recombinant products and the clinical and economic implications: a meeting report Conference Paper
- Family Physician attitudes about prescribing using a drug formulary Academic Article
- General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial Academic Article
- Glycoprotein IIb/IIIa Receptor Therapy in Percutaneous Coronary Intervention and Non???ST-Segment Elevation Acute Coronary Syndromes Academic Article
- Haemophilia prophylaxis: how can we justify the costs? Academic Article
- Healing an ailing pharmaceutical system: prescription for reform for United States and Canada Academic Article
- Health economic evaluation of rivaroxaban in the treatment of patients with chronic coronary artery disease or peripheral artery disease Academic Article
- Health economics of gastroesophageal reflux disease. Academic Article
- Highly Priced Gene Therapies: A Wake-Up Call for Early Price Regulation Academic Article
- How do researchers determine the difference to be detected in superiority trials? Results of a survey from a panel of researchers Academic Article
- Impact of Cardiac Implantable Electronic Device Infection Academic Article
- Impact of a clinical pharmacist in a multidisciplinary intensive care unit Academic Article
- Impact of a restrictive drug access program on the risk of cardiovascular encounters in children exposed to ADHD medications. Academic Article
- Impact of antibiotic treatment duration on outcomes in older men with suspected urinary tract infection: Retrospective cohort study Academic Article
- Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs. Academic Article
- Increased Eligibility for Treatment of Chronic Hepatitis C Infection with Shortened Duration of Therapy: Implications for Access to Care and Elimination Strategies in Canada Academic Article
- Incremental costs of fragility fractures: a population-based matched -cohort study from Ontario, Canada Academic Article
- Incremental healthcare utilisation and costs among new senior high-cost users in Ontario, Canada: a retrospective matched cohort study Academic Article
- Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial Academic Article
- Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians Academic Article
- Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009 Academic Article
- Management of venous thromboembolism in patients with cancer: role of dalteparin Academic Article
- Medication use and its impact on high-cost health care users among older adults: protocol for the population-based matched cohort HiCOSTT study Academic Article
- Meta-Analysis of Randomized Controlled Trials of Prophylactic Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor After Autologous and Allogeneic Stem Cell Transplantation Academic Article
- Misdiagnosis of bipolar disorder as borderline personality disorder: clinical and economic consequences Academic Article
- NCDs and the WHO Essential Medicines Lists: children need universal health coverage too Academic Article
- Nonulcer dyspepsia and proton pump inhibitors Academic Article
- Optimizing the use of prescription drugs in Canada through the Common Drug Review Academic Article
- Oral steroids for the resolution of otitis media with effusion (OME) in children (OSTRICH): study protocol for a randomised controlled trial Academic Article
- PHARMAC and treatment of bipolar depression--the limits of utilitarianism. Academic Article
- Palbociclib in hormone receptor positive advanced breast cancer: A cost-utility analysis Academic Article
- Patient characteristics and costs of severe sepsis and septic shock in Quebec Academic Article
- Patients’ Willingness-to-Pay for an Alzheimer’s Disease Medication in Canada Academic Article
- Population-Based Study to Determine the Health System Costs of Using the 21-Gene Assay Academic Article
- Prevention of catheter lumen occlusion with rT-PA versus heparin (Pre-CLOT): study protocol of a randomized trial [ISRCTN35253449] Academic Article
- Re: Cost-Effectiveness of Aspirin Chemoprevention for Barrett's Esophagus Academic Article
- Reference-based pricing (RBP) of prescription drugs. Academic Article
- Resource Use and costs of End-Of-Life/Palliative Care: Ontario Adult Cancer Patients Dying during 2002 and 2003 Academic Article
- Resource use and costs of treating acute cough/lower respiratory tract infections in 13 European countries: results and challenges Academic Article
- Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme Academic Article
- Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data Academic Article
- Screening for Osteoporosis in Postmenopausal Women With Breast Cancer Receiving Aromatase Inhibitors: Less Is More? Academic Article
- Socioeconomic factors and use of secondary preventive therapies for cardiovascular diseases in South Asia: The PURE study Academic Article
- Stakeholders’ feedback on the proposed recommendations for updating the patented medicine prices review board (pmprb) budget impact analysis guidelines Academic Article
- Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia Academic Article
- The Cost of Clopidogrel Use in Atrial Fibrillation in the ACTIVE-A Trial Academic Article
- The Diagnosis of Urinary Tract Infection in Young Children (DUTY) Study Clinical Rule: Economic Evaluation Academic Article
- The Effect of ICU Sedation Guidelines and Pharmacist Interventions on Clinical Outcomes and Drug Cost Academic Article
- The German method for setting ceiling prices for drugs: in some cases less data are required Academic Article
- The Role of Benzodiazepines in the Treatment of Insomnia Academic Article
- The burden of illness of osteoporosis in Canada Academic Article
- The cost burden of clinically significant esophageal anastomotic leaks—a steep price to pay Academic Article
- The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada Academic Article
- The impact of recombinant human erythropoietin on medical care costs for hemodialysis patients in Canada Academic Article
- The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study Academic Article
- The unintended (and costly) effects due to the introduction of an unrestricted reimbursement policy for atypical antipsychotic medications in a Canadian public prescription drug program: 1996/97 to 2005/06. Academic Article
- Use, costs, and predictors of psychiatric healthcare services following an autism spectrum diagnosis: Population-based cohort study Academic Article
- Using Value-of-Information Methods when the Disease Is Rare and the Treatment Is Expensive—The Example of Hemophilia A Academic Article
- Valuing Outcomes in Health Care Academic Article
- What Is the Economic Value of Digoxin Therapy in Congestive Heart Failure Patients? Results From the DIG Trial Academic Article
- When are Pharmaceuticals Priced Fairly? An Alternative Risk-Sharing Model for Pharmaceutical Pricing Academic Article